Personalized accelerated chemoradiation for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a personalized, faster course of radiation combined with chemotherapy for lung cancer. It aims to improve treatment effectiveness while reducing side effects by tailoring the radiation plan to each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lung cancer or another cancer in the chest area.
- You are scheduled to receive radiation therapy (about 60-66 Gy) along with chemotherapy as your main treatment.
- You are generally able to care for yourself (ECOG performance status 0-2).
- You are 18 years or older.
- You have not had radiation to the chest before that would overlap with this new treatment.
- You do not have interstitial pulmonary fibrosis (a type of lung scarring).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a more intensive form of targeted radiation, combined with immunotherapy (immune checkpoint inhibitors), can work better and be safe for people with advanced non-small cell lung cancer. You may be considered if your tumor is limited in size and you’re able to receive both treatments.
This trial studies a new way of giving radiation therapy to the chest for lung cancer that is growing quickly. The approach uses a special schedule to damage the cancer more effectively, which might improve how well the treatment works.
This trial tests combining immunotherapy with a shorter course of chemoradiation for locally advanced non-small cell lung cancer that hasn't spread. It aims to see if this approach is more effective and tolerable than standard treatment.
This study tests using a shorter course of radiation (hypofractionated radiotherapy) combined with immunotherapy for people with limited-stage small-cell lung cancer. The goal is to see if this approach works better at controlling the cancer and may cause fewer side effects.
This trial tests a new approach to radiation therapy for central lung cancers, giving high doses in very short bursts to see if it's safe and effective. It may be an option for people whose tumors are not too large and are in a specific central location.
This trial tests if giving a higher dose of radiation to tumors in the chest (lungs or nearby areas) can better control symptoms or prevent them from getting worse. It is for people who need palliative radiation—treatment aimed at easing discomfort or slowing tumor growth, not curing the cancer.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.